Gabapentin therapy for ocular opsoclonus-myoclonus restores eye movement communication in a patient with a locked-in syndrome.

Abstract	The experience with a patient with locked-in syndrome suffering from opsoclonus-myoclonus symptoms is described: gabapentin successfully reversed the symptoms, just favoring the regaining of eye-dependent communication strategies.
Authors	Francesca Pistoia, Marco Sarà
Journal	Neurorehabilitation and neural repair (Neurorehabil Neural Repair) Vol. 24 Issue 5 Pg. 493-4 (Jun 2010) ISSN: 1552-6844 [Electronic] United States
PMID	19933381 (Publication Type: Case Reports, Journal Article)
Chemical References	Amines Anticonvulsants Cyclohexanecarboxylic Acids gamma-Aminobutyric Acid Gabapentin
Topics	Adult Amines (therapeutic use) Anticonvulsants (therapeutic use) Cerebral Infarction (complications, pathology) Cyclohexanecarboxylic Acids (therapeutic use) Female Gabapentin Humans Magnetic Resonance Imaging (methods) Ocular Motility Disorders (drug therapy, etiology) Opsoclonus-Myoclonus Syndrome (drug therapy, etiology) Pons (pathology) Quadriplegia (complications) gamma-Aminobutyric Acid (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!